Key Highlights
- Launch of fingertip blood collection technology using BD’s MiniDraw™ and Babson’s BetterWay for U.S. health systems.
- Revolutionizes access with fewer barriers to blood testing, requiring just six drops of blood from a finger.
- Expands blood testing capabilities to underserved locations and ambulatory care settings, reducing the need for phlebotomy.
Source: PR Newswire
Notable Quotes
- “By simplifying one of the most common procedures, together we’re making blood testing less invasive and more convenient to help health care organizations increase efficiency and access while helping to improve patient satisfaction and outcomes.” — Bridget Bagnato, Worldwide President of Specimen Management at BD
- “BD has been innovating blood collection technology for 75 years, and we believe our partnership will deliver a potentially transformative technology to support innovative and patient-focused health care organizations in better reaching and serving patients.” — David Stein, CEO at Babson Diagnostics
SoHC's Take
This collaboration between BD and Babson Diagnostics marks a significant milestone in making blood testing more accessible, efficient, and patient-friendly. By addressing common challenges such as fear of needles and phlebotomy shortages, this innovation ensures diagnostic services can reach underserved and rural areas with greater ease. The strategic integration of BD’s MiniDraw™ and Babson’s BetterWay technologies highlights the importance of advancing healthcare accessibility, particularly in ambulatory and community care settings. This development is poised to not only improve health equity but also enhance patient outcomes across the board.
